Details
 

August 20, 2020
12:00-1:00PM

Oncology Pharmacist Lunch & Lecture Series

New Drug Updates: Oral Oncolytics

WEBINAR

Claire Saadeh, PharmD, BCOP
Professor, Pharmacy Practice
Ferris State University
Sparrow Health System

Approximately 25% of the new chemotherapy drugs coming up for FDA approval are oral oncolytics. It is important to keep up with these drugs to ensure that patients are receiving the correct agent based on specific mutations within cancer cells, and the appropriate dosing is employed. These agents also require comprehensive patient education, adherence monitoring, safety monitoring, and side effect management that all pharmacists and technicians should be familiar with.

CEU Information:
1.0 Contact Hour; Knowledge-based Activity, Initial Release Date: 8/20/20; Expiration Date: 8/20/21

Any individual who is more than 10 minutes late to an activity or leaves an activity early will not be granted PCE credit. This procedure will be strictly enforced, so please plan accordingly.

Target Audience:
Continuing education programs were designed specifically for pharmacists, pharmacy technicians and student pharmacists.

Live Activity:
ACPE Universal Activity #0112-9999-20-308-L01-P & #0112-9999-20-308-L01-T

Home Study Activity:
ACPE Universal Activity #0112-9999-20-308-H01-P & #0112-9999-20-308-H01-T

Oncology Pharmacist Lunch & Lecture Brochure

Speaker Bio:
Dr. Claire Saadeh is currently a Professor of Pharmacy Practice with Ferris State University College of Pharmacy and a Board Certified Oncology Pharmacist (BCOP), specializing in the areas of oncology, pain management, and palliative care. Dr. Saadeh’s current clinical practice site is at Sparrow Health System in Lansing where she works with the department of pharmacy, in-patient palliative care team, and the Herbert Herman Cancer Center.

Click Here to Register Today!

Thank you to our webinar sponsors:

Abbvie      Amgen      AstraZeneca      Bei Gene Logo      GSK Oncology      Janssen Cropped      Merck      Pfizer      Sanofi      Takeda Logo

      

For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.

Printer-Friendly Version


2020-08-20 2020-08-20 13:00:00 America/Detroit Oncology Pharmacist Lunch & Lecture Series Claire Saadeh, PharmD, BCOPProfessor, Pharmacy PracticeFerris State UniversitySparrow Health System Approximately 25% of the new chemotherapy drugs coming up for FDA approval are oral oncolytics. It is important to keep up with these drugs to ensure that patients are receiving the correct agent based on specific mutations within cancer cells, and the appropriate dosing is employed. These agents also require comprehensive patient education, adherence monitoring, safety monitoring, and side effect management that all pharmacists and technicians should be familiar with. CEU Information:1.0 Contact Hour; Knowledge-based Activity, Initial Release Date: 8/20/20; Expiration Date: 8/20/21 Any individual who is more than 10 minutes late to an activity or leaves an activity early will not be granted PCE credit. This procedure will be strictly enforced, so please plan accordingly. Target Audience:Continuing education programs were designed specifically for pharmacists, pharmacy technicians and student pharmacists. Live Activity: ACPE Universal Activity #0112-9999-20-308-L01-P & #0112-9999-20-308-L01-T Home Study Activity: ACPE Universal Activity #0112-9999-20-308-H01-P & #0112-9999-20-308-H01-T Oncology Pharmacist Lunch & Lecture Brochure Speaker Bio:Dr. Claire Saadeh is currently a Professor of Pharmacy Practice with Ferris State University College of Pharmacy and a Board Certified Oncology Pharmacist (BCOP), specializing in the areas of oncology, pain management, and palliative care. Dr. Saadeh’s current clinical practice site is at Sparrow Health System in Lansing where she works with the department of pharmacy, in-patient palliative care team, and the Herbert Herman Cancer Center. Click Here to Register Today! Thank you to our webinar sponsors:                                                               For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org. WEBINAR